CLINICAL TRIAL / NCT05134480

Impact of Donor Diabetes on DMEK Success and Endothelial Cell Loss

  • Interventional
  • Active
  • NCT05134480

Contact Information

  • Justin Bell

Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes on Corneal Transplant Success and Endothelial Cell Loss

This double-masked multi-center trial will evaluate the association of diabetes in the cornea donor with transplant success and loss of endothelial cells through 5 years following Descemet membrane endothelial keratoplasty (DMEK). Study eyes are assigned to receive either a cornea from a donor without diabetes or a cornea from a donor with diabetes.